Post job

Shire Pharmaceuticals Inc's revenue is $15.2 billion.

What is Shire Pharmaceuticals Inc's revenue?

Shire Pharmaceuticals Inc's annual revenue is $15.2B. Zippia's data science team found the following key financial metrics about Shire Pharmaceuticals Inc after extensive research and analysis.
  • Shire Pharmaceuticals Inc's peak quarterly revenue was $4.1B in 2017(q4).
  • Shire Pharmaceuticals Inc's revenue growth from 2003 to 2017 is 1,151.32%.
  • Shire Pharmaceuticals Inc has 3,500 employees, and the revenue per employee ratio is $4,331,600.
  • Shire Pharmaceuticals Inc peak revenue was $15.2B in 2017.
  • Shire Pharmaceuticals Inc annual revenue for 2016 was 11.4B, 77.61% growth from 2015.
  • Shire Pharmaceuticals Inc annual revenue for 2017 was 15.2B, 33.03% growth from 2016.

On this page

Most recent quarter revenue
$3.9B (Q3'2018)
Company most recent quarter revenue
Peak revenue
$15.2B (2017)
Company peak revenue
Revenue / employee
$4.3M
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$3.9B (Q3'2018)
Company most recent quarter revenue
Peak revenue
$15.2B (2017)
Company peak revenue
Revenue / employee
$4.3M
Company revenue / employee

Shire Pharmaceuticals Inc historical revenue

Shire Pharmaceuticals Inc's peak revenue was $15.2B in 2017. The peak quarterly revenue was $4.1B in 2017(q4).

Shire Pharmaceuticals Inc's revenue increased from $1.2b in 2003 to $15.2B currently. That's a 1,151.32% change in annual revenue.

Shire Pharmaceuticals Inc annual revenue

$15B
$12B
$9B
$6B
$3B
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017

Shire Pharmaceuticals Inc annual revenue over time

Fiscal year / yearShire Pharmaceuticals Inc revenue
2009$3.0B
2010$3.5B
2011$4.2B
2012$4.5B
2013$4.9B
2014$6.0B
2015$6.4B
2016$11.4B
2017$15.2B

Rate Shire Pharmaceuticals Inc's financial transparency

Zippia waving zebra

Shire Pharmaceuticals Inc annual growth

Shire Pharmaceuticals Inc saw the greatest revenue growth in 2016, when revenue increased by 77.61%.

Shire Pharmaceuticals Inc had the lowest revenue growth in 2009, when revenue changed by -0.48%.

Shire Pharmaceuticals Inc annual growth rate over time

YearShire Pharmaceuticals Inc growth
2009
-0%
2010
15%
2011
20%
2012
9%
2013
9%
2014
22%
2015
7%
2016
78%
2017
33%

Shire Pharmaceuticals Inc quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$4B
$3B
$2B
$2B
$829M
$0
2014
2015
2016
2017
2018

Shire Pharmaceuticals Inc quarterly growth rate over time

YearQ1Q2Q3Q4
2009$817.8M$629.7M$667.0M$893.3M
2010$816.2M$849.4M$874.3M$931.2M
2011$972.2M$1.1B$1.1B$1.0B
2012$1.2B$1.2B$1.1B$1.0B
2013$1.1B$1.3B$1.2B$1.3B
2014$1.3B$1.5B$1.6B$1.6B
2015$1.5B$1.6B$1.7B$1.7B
2016$1.7B$2.4B$3.5B$3.8B
2017$3.6B$3.7B$3.7B$4.1B
2018$3.8B$3.9B$3.9B-

Shire Pharmaceuticals Inc jobs nearby

Do you work at Shire Pharmaceuticals Inc?

Is Shire Pharmaceuticals Inc transparent about its revenue structure?

Shire Pharmaceuticals Inc financial information

CEOFlemming Ornskov
Company TypePrivate
Employees Number3,500
Date Founded2004
HeadquartersWayne, Pennsylvania
Number of Locations3
Revenue$15.2B
Net Income$4,271,500,000
Gross Proft$10.5B (2017)
Tax Rate-1.2%
Total Assets$67,756,900,000
TickerSHPGF

Shire Pharmaceuticals Inc jobs you might like

Shire Pharmaceuticals Inc competitors

Shire Pharmaceuticals Inc's top competitor, Mylan, earned an annual revenue of $11.5B.

Shire Pharmaceuticals Inc's smallest competitor is Enzon Pharmaceuticals with revenue of $26.0K last year.

Shire Pharmaceuticals Inc revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Shire Pharmaceuticals Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Shire Pharmaceuticals Inc. The employee data is based on information from people who have self-reported their past or current employments at Shire Pharmaceuticals Inc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Shire Pharmaceuticals Inc. The data presented on this page does not represent the view of Shire Pharmaceuticals Inc and its employees or that of Zippia.

Shire Pharmaceuticals Inc may also be known as or be related to Shire Pharmaceuticals and Shire Pharmaceuticals Inc.